Internal Medicine, Cardiovascular Disease · Lakewood, CA
NPI
1851473003
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3300 E South St Ste 301
Lakewood, CA, 90805
Phone (562) 622-9500
Groups this clinician bills Medicare through
Medicare paid, 2024
$125K
1,576 services
Medicare patients, 2024
399
Average age 76
Drug cost, 2024
$2.8M
7,757 prescriptions
Company payments, 2025
$2,022
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Konstantinos Vlachonassios was code 99214 (office e&m - established), 521 times for 199 patients. In total Konstantinos Vlachonassios billed 1,576 services in 44 codes, and Medicare paid $125K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-12-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 521 | 199 | $85.98 | $45K |
| 99233 Hospital E&M - Subsequent | Facility | 324 | 71 | $88.25 | $29K |
| 93306 Echocardiography (TTE/TEE) | Facility | 120 | 114 | $50.49 | $6,059 |
| 93010 Electrocardiogram | Facility | 113 | 98 | $6.07 | $686 |
| 99223 Hospital E&M - Initial | Facility | 81 | 73 | $127.76 | $10K |
| 99213 Office E&M - Established | Office | 71 | 58 | $56.28 | $3,996 |
| 93306 Echocardiography (TTE/TEE) | Office | 52 | 49 | $156.47 | $8,137 |
| 99215 Office E&M - Established | Office | 52 | 39 | $119.20 | $6,198 |
| 93000 Electrocardiogram | Office | 48 | 47 | $9.77 | $469 |
| 93288 External Electrocardiographic Monitoring | Office | 37 | 21 | $37.95 | $1,404 |
| 99205 Office E&M - New | Office | 25 | 25 | $136.01 | $3,400 |
| 93018 Electrocardiogram | Facility | 18 | 18 | $10.00 | $180 |
| 93016 Electrocardiogram | Facility | 18 | 18 | $14.87 | $268 |
| 93458 Percutaneous Transcatheterization | Facility | 12 | 12 | $180.40 | $2,165 |
By year: 2022 $187K for 2,041 services; 2023 $166K for 1,766 services; 2024 $125K for 1,576 services.
Medicare prescription drug claims, 2024
In 2024, the drug Konstantinos Vlachonassios prescribed most often to Medicare patients was Amlodipine Besylate, with 424 prescriptions and refills. In total Konstantinos Vlachonassios wrote 7,757 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 424 | 1,119 | 142 | $2,843 |
| Ezetimibe Generic | 388 | 1,132 | 133 | $13K |
| Atorvastatin Calcium Generic | 376 | 1,063 | 120 | $4,208 |
| Furosemide Generic | 267 | 731 | 104 | $1,777 |
| Rosuvastatin Calcium Generic | 266 | 776 | 86 | $5,513 |
| Hydralazine Hcl Generic | 264 | 675 | 81 | $4,841 |
| Metoprolol Succinate Generic | 254 | 712 | 84 | $4,626 |
| Eliquis Apixaban | 247 | 466 | 64 | $264K |
| Jardiance Empagliflozin | 235 | 431 | 59 | $241K |
| Nebivolol Hcl Generic | 207 | 555 | 62 | $14K |
| Telmisartan Generic | 204 | 548 | 71 | $5,946 |
| Olmesartan Medoxomil Generic | 193 | 538 | 66 | $4,032 |
| Chlorthalidone Generic | 189 | 522 | 73 | $3,569 |
| Xarelto Rivaroxaban | 174 | 310 | 39 | $165K |
| Carvedilol Generic | 167 | 475 | 50 | $2,156 |
Brand drugs: - claims; generic drugs: 5,706 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Konstantinos Vlachonassios $2,022 ($2,022 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abiomed with $300.
| Company | Payments | Amount |
|---|---|---|
| Abiomed JNJ | 4 | $300 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $265 |
| Merck Sharp & Dohme LLC MRK | 7 | $228 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $180 |
| Biotronik Inc. | 6 | $176 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $145 |
| Kestra Medical Technology Services, Inc. | 4 | $144 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $113 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $111 |
| Edwards Lifesciences Corporation EW | 5 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.